Author:
Jakesz R.,Samonigg H.,Gnant M.,Kubista E.,Steindorfer P.,Hausmaninger H.,Sevelda P.,Tschurtschenthaler B.,Fridrik M.,Stierer M.,Kolb R.,Steger G.,the Austrian Breast Cancer Study Group
Reference44 articles.
1. Fisher B, Redmond C, Dimitro NV, et al. A randomized clinical trial evaluating sequential methorexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Eng J Med 1989, 320, 473–478.
2. Mansour EG, Gray R, Shatila AH, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an intergroup study. N Engl J Med 1989, 320, 485–490.
3. The Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node negative breast cancer. N Engl J Med 1989, 320, 491–495.
4. Senn H, Barett-Mahler A, Jungi W, et al. Adjuvant chemoimmunotherapy with LMF+BCG in node-negative and node-positive breast cancer patients: 10 year results. Eur J Clin Oncol 1989, 25, 513–525.
5. Bonadonna G, Valagussa P, Zambetti M, et al. Milan adjuvant trials for stage I–II breast cancer. Adjuvant Therapy of Cancer V. Orlando, FL, Grune & Stratton, 1987, 211–221.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献